Tuesday, 21 August 2018

Drug Discovery News

  • HitGen collaborates with LG Chem

    Drug Discovery |  News | 0 Comment | 20 Aug, 2018

    HitGen Ltd has announced a multi-year major drug discovery research collaboration with LG Chem to identify novel small molecule leads for targets of interest. In this collaboration, HitGen ...Read more

  • Blueberry Therapeutics raises £10M funding to develop nanomedicines

    Drug Discovery |  News | 0 Comment | 16 Aug, 2018

    Blueberry Therapeutics Limited, a drug discovery and development company focused on developing innovative nanomedicines for difficult to treat skin and nail infections, has successfully com...Read more

  • Multi- institutional alliance to develop anti-aging drugs

    Drug Discovery |  News | 0 Comment | 16 Aug, 2018

    The Buck Institute, Juvenescence, and Insilico Medicine have announced a research collaboration utilizing artificial intelligence (AI) to discover and develop novel anti-aging therapeutics ...Read more

  • FDA approves Amicus' Galafold for Fabry disease

    Drug Discovery |  News | 0 Comment | 13 Aug, 2018

    Singapore – The U.S. Food and Drug Administration recently approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease. The drug is indica...Read more

  • Pfizer's Innovative drug IBRANCE gets China approval

    Drug Discovery |  News | 0 Comment | 08 Aug, 2018

    Pfizer China announced that the China National Drug Administration (CNDA) has granted approval of IBRANCE® (palbociclib) on July 31st, the first cyclin-dependent Kinase 4/6 (CDK4/6) inh...Read more

  • DotBio successfully raises $2.3 M in seed financing

    Drug Discovery |  News | 0 Comment | 07 Aug, 2018

    Singapore – DotBio, a new company focused on the development of novel immuno-oncology drugs based on humanized domain antibodies, has officially launched and has successfully rai...Read more

  • Medpacto inks deal with AstraZeneca

    Drug Discovery |  News | 0 Comment | 02 Aug, 2018

    MedPacto, that announced today a clinical collaboration with AstraZeneca to evaluate the safety and efficacy of MedPacto’s vactosertib (TEW-7197), a small molecule, oral inhibitor of ...Read more

  • Pfizer's Herceptin biosimilar approved in Europe

    Drug Discovery |  News | 0 Comment | 31 Jul, 2018

    Singapore – The European Commission approves Pfizer's TRAZIMERA, a biosimilar of Roche's cancer med Herceptin (trastuzumab). TRAZIMERA, a potential biosimilar to ...Read more

  • Nektar's back pain opioid gets approval for FDA review

    Drug Discovery |  News | 0 Comment | 30 Jul, 2018

     Singapore- The FDA accepts for review Nektar Therapeutics' marketing application seeking approval for NKTR-181 for the treatment of chronic low back pain in adult patients n...Read more

  • Agios receives nod for ivosidenib

    Drug Discovery |  News | 0 Comment | 23 Jul, 2018

    Singapore – The FDA approves Agios Pharmaceuticals' TIBSOVO (ivosidenib) for the treatment of adult patients with relapsed/refractory acute myeloid leukemia (AML) with a sus...Read more

  • FDA approves Pfizer's biosimilar

    Drug Discovery |  News | 0 Comment | 23 Jul, 2018

    Singapore – US Food and Drug Administration approves Pfizer’s Neupogen biosimilar Nivestym and is expected to hit the market at a significant discount to its reference drug. Th...Read more

  • FDA approves first drug indicating treatment of smallpox

    Drug Discovery |  News | 0 Comment | 16 Jul, 2018

     Singapore – The U.S. Food and Drug Administration approved TPOXX (tecovirimat), the first drug with an indication for treatment of smallpox. Though the World Health Or...Read more

  • Immatics, Genmab to develop bispecific cancer immunotherapies

    Drug Discovery |  News | 0 Comment | 12 Jul, 2018

    Immatics Biotechnologies GmbH, a clinical-stage biopharmaceutical company active in the discovery and development of T-cell redirecting cancer immunotherapies, has entered into a research c...Read more

  • FDA grants 7-year orphan drug exclusivity to Eagle

    Drug Discovery |  News | 0 Comment | 09 Jul, 2018

    Singapore – Eagle Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted seven years of orphan drug exclusivity (ODE) in the U.S., for BENDEKA (be...Read more

  • FDA grants ODD to OBI Pharma's lead investigational drug candidate

    Drug Discovery |  News | 0 Comment | 09 Jul, 2018

    OBI Pharma, a Taiwan biopharma company, has announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for OBI-3424 for the Treatment of ...Read more

  • Biogen’s Alzheimer’s drug succeeds in trial

    Drug Discovery |  News | 0 Comment | 06 Jul, 2018

    Singapore – Eisai and Biogen have announced positive topline results from the Phase II study with BAN2401, an anti-amyloid beta protofibril antibody, in 856 patients with early A...Read more

  • Roche announces positive results of lung cancer drug Tecentriq

    Drug Discovery |  News | 0 Comment | 04 Jul, 2018

    Global pharma giant recently announced that its drug candidate for cancer- the combination of Tecentriq (atezolizumab) plus chemotherapy (Celgene’s Abraxane [albumin-bound paclitaxel;...Read more

  • Singapore institutes collaborate with ROK to develop innovative drugs

    Drug Discovery |  News | 0 Comment | 03 Jul, 2018

    Singapore – Scientists and clinicians from Singapore institutes are collaborating with C&C Research Laboratories, a leading research institute from the Republic of Korea...Read more

Survey Box

Is provision of cheap drugs having limited effects in the fight against HCV in SE Asia?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls